BVMF/B1SX34 (BVMF/B1SX34)

Brazil Stock Exchange: BVMF/B1SX34 · BRL

R$59.9

-1.56 (-2.5%)· Recorded snapshot

Market cap	349.2B
Revenue (ttm)	109.1B
Net income (ttm)	18.1B
EPS (ttm)	R$3.17
P/E (trailing)	18.9x
P/E (forward)	13.4x
Volume	118
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 109.1B
Net income (ttm): 18.1B
EPS (ttm): R$3.17
P/E (trailing): 18.9x
P/E (forward): 13.4x
Market cap: 349.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E13.4

P25 n/aP50 n/aP75 n/a

Trailing P/E18.9

P25 n/aP50 n/aP75 n/a

ROE15.3

P25 n/aP50 n/aP75 n/a

ROIC11.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/B1SX34 indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-28
Employees	59,000
Employees change	5,000
Employees growth	10.42%
Enterprise value	BRL 415.1B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1979
Industry	Medical Devices
Is primary listing	No
ISIN number	BRB1SXBDR006
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2026-07-27
Last stock split type	Forward
Market cap	BRL 349.2B
Next earnings date	2026-10-28
Price	BRL 59.94
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-27
Symbol	bvmf/B1SX34
Website	https://www.bostonscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	76.84x
Average P/E ratio (3Y)	50.98x
Average P/E ratio (5Y)	62.9x
Earnings yield	5.28%
EV/Earnings	22.88x
EV/EBIT	17.89x
EV/EBITDA	13.35x
EV/FCF	21.41x
EV/Sales	3.68x
FCF / EV yield	4.67%
FCF yield	5.55%
Forward P/E	13.37x
Graham number	39.60115
Graham upside	-33.93%
Lynch fair value	BRL 77.85
Lynch upside	29.88%
P/(FCF - SBC) ratio	19.75x
P/(OCF - SBC) ratio	15.51x
P/B ratio	2.68x
P/E ratio	18.93x
P/FCF ratio	18.01x
P/OCF ratio	14.41x
P/S ratio	3.2x
Price/EBITDA ratio	11.68x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	20.6%
EBITDA margin	27.38%
Effective tax rate	4.43%
FCF margin	17.27%
Gross margin	68.94%
Operating margin	20.6%
Pretax margin	17.35%
Profit margin	16.62%
Profit per employee	BRL 307,458
Profitable quarters	23
Profitable years	5
Revenue per employee	BRL 1.8M
ROA	6.19%
ROA (5Y)	4.61%
ROCE	11.08%
ROE	15.34%
ROE (5Y)	8.1%
ROIC	11.13%
ROIC (5Y)	7.52%
SBC / revenue	1.52%
Tax / revenue	0.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	26.63%
EPS growth (Q)	-21.5%
EPS growth (QoQ)	-34.43%
EPS growth 10Y	46.25%
EPS growth 3Y	42.32%
EPS growth 5Y	25.24%
EPS growth quarters	7
EPS growth years	3
FCF growth	4.02%
FCF growth 3Y	33.93%
FCF growth 5Y	14.35%
Gross profit growth	8.88%
Gross profit growth (Q)	-3.23%
Gross profit growth 3Y	15.2%
Gross profit growth 5Y	12.47%
Net income growth	25.48%
Net income growth (Q)	-22.91%
Net income growth (QoQ)	-35.83%
Net income growth 3Y	43.26%
Net income growth 5Y	26.04%
Net income growth quarters	7
Net income growth years	3
OCF growth	5.69%
OCF growth 10Y	13.52%
OCF growth 3Y	28.69%
OCF growth 5Y	15.09%
Operating income growth	13.05%
Operating income growth (Q)	-6.76%
Operating income growth 3Y	23.11%
Operating income growth 5Y	17.01%
Revenue growth	8.89%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	-5.59%
Revenue growth 10Y	10.04%
Revenue growth 3Y	15.27%
Revenue growth 5Y	12.93%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -4.8B
Depreciation and amortization	BRL 7.6B
EBIT	BRL 22.5B
EBITDA	BRL 29.9B
EPS	BRL 3.17
Financing cash flow	BRL -5.1B
Free cash flow	BRL 19.4B
Free cash flow minus SBC	BRL 17.7B
Gross profit	BRL 75.2B
Income taxes	BRL 839.1M
Investing cash flow	BRL -19B
Net borrowing	BRL 5.2B
Net cash flow	BRL 64.2M
Net income	BRL 18.1B
Operating cash flow minus SBC	BRL 22.5B
Operating income	BRL 22.5B
Revenue	BRL 109.1B
Stock-based compensation	BRL 1.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 89.26
Debt / EBITDA	2.17
Debt / equity	0.5
Debt / FCF	3.37
Interest coverage	11.57
Net cash (debt)	BRL -62.6B
Net cash / market cap	-17.93%
Net debt / EBITDA	2.09
Net debt / equity	0.48
Net debt / FCF	3.23
Piotroski F-Score	5
Shareholders' equity	BRL 130.4B
Tangible book value	BRL -3.3B
Tangible book value per share	BRL -2.25
Total cash	BRL 2.8B
Total debt	BRL 65.4B
WACC	6.69%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.24
Inventory turnover	2.12
Quick ratio	0.56
Working capital	BRL 8.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.91%
Shareholder yield	0.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 67.21
1D price change	-2.54%
1M price change	4.52%
1M total return	4.52%
1W price change	5.29%
1W total return	5.29%
1Y price change	-55.97%
1Y return CAGR	-56%
1Y total return	-55.97%
20-day SMA	BRL 55.98
200-day SMA	BRL 80.00
3M price change	9.29%
3M total return	9.29%
3Y price change	-4.38%
3Y return CAGR	-1.48%
3Y total return	-4.38%
50-day SMA	BRL 58.98
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 139.19
52-week high date	2025-11-13
52-week low	BRL 50.29
52-week low date	2026-07-23
5Y price change	-3.03%
5Y return CAGR	-0.61%
5Y total return	-3.03%
6M price change	-23.15%
6M total return	-23.15%
All-time high	BRL 153.78
All-time high date	2025-02-10
All-time low	BRL 33.62
All-time low date	2020-03-18
Average true range (ATR)	BRL 1.58
Average volume	708.6
Beta (5Y)	0.58
Change from 52-week high	-56.94%
Change from 52-week low	19.19%
Change from all-time high	-61.02%
Change from all-time low	78.31%
Change from open	0.02%
Day's gap	-2.55%
Dollar volume	BRL 7,073
High price	BRL 60.24
Low price	BRL 59.93
Monthly RSI	30.78
Open price	BRL 59.93
Position in 52-week range	3.23%
Previous close	BRL 61.50
Price vs 150-day SMA	-10.81%
Price vs 20-day SMA	7.07%
Price vs 200-day SMA	-25.07%
Price vs 50-day SMA	1.63%
Relative volume	0.17
RSI	59.65
Sharpe ratio	-2.02
Sharpe ratio (3Y)	-0.06
Sharpe ratio (5Y)	0.02
Sortino ratio	-2.34
Sortino ratio (3Y)	0.09
Sortino ratio (5Y)	0.22
Volume	118
Weekly RSI	38.39
YTD price change	-54.63%
YTD total return	-54.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4B
Shares change (QoQ)	-1.55%
Shares change (YoY)	-0.91%
Shares held by insiders	0.18%
Shares held by institutions	93.2%

Deeper analysis on BVMF/B1SX34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/B1SX34 report

Is a complete BVMF/B1SX34 research report available?

No complete published report is available for bvmf/B1SX34 (BVMF/B1SX34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/B1SX34 (BVMF/B1SX34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/B1SX34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/B1SX34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/B1SX34

Frequently asked questions